[Ip-health] USPTO "clarifies" June 27, 2012 testimony on biologics exclusivity and India compulsory license | Knowledge Ecology International

Jamie Love james.love at keionline.org
Tue Jul 3 21:02:24 PDT 2012

Both USPTO and USTR have issued clarifications or corrections to Teresa
Stanek Rea's June 27, 2012 testimony before the
House Judiciary Subcommittee on Intellectual Property, Competition and the

USPTO clarified its statements on the India compulsory license and
corrected its statement on support for 12 years of test data protection for
biologic drugs in the TPPA.

USTR issued a statement on biologics test data in the TPPA.


More information about the Ip-health mailing list